IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALTOMARE, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.384
NA - Nord America 1.294
EU - Europa 618
SA - Sud America 442
AF - Africa 42
OC - Oceania 4
Totale 3.784
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.240
SG - Singapore 591
BR - Brasile 363
CN - Cina 296
VN - Vietnam 153
HK - Hong Kong 140
DE - Germania 133
IT - Italia 111
RU - Federazione Russa 68
GB - Regno Unito 64
FR - Francia 60
TR - Turchia 55
IN - India 33
CZ - Repubblica Ceca 32
CA - Canada 29
AR - Argentina 28
BD - Bangladesh 28
AT - Austria 26
UA - Ucraina 26
FI - Finlandia 23
NL - Olanda 18
EC - Ecuador 17
JP - Giappone 16
MX - Messico 16
ZA - Sudafrica 14
ID - Indonesia 13
PL - Polonia 13
SE - Svezia 12
IQ - Iraq 9
PY - Paraguay 8
ES - Italia 7
PK - Pakistan 7
VE - Venezuela 7
CL - Cile 6
CO - Colombia 6
KE - Kenya 6
UZ - Uzbekistan 6
BE - Belgio 5
JO - Giordania 5
MA - Marocco 5
PE - Perù 5
SA - Arabia Saudita 5
AZ - Azerbaigian 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
PA - Panama 3
PT - Portogallo 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AU - Australia 2
EG - Egitto 2
ET - Etiopia 2
IE - Irlanda 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GA - Gabon 1
GM - Gambi 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
QA - Qatar 1
TH - Thailandia 1
UY - Uruguay 1
Totale 3.784
Salva come PNG Salva come JPEG
Città #
Singapore 289
Ashburn 153
San Jose 144
Hong Kong 140
The Dalles 118
Beijing 63
Ho Chi Minh City 53
Los Angeles 50
Lauterbourg 49
New York 48
Dallas 47
Istanbul 47
Munich 40
Hanoi 38
Boardman 35
Fairfield 32
Nuremberg 32
Des Moines 31
Santa Clara 29
Moscow 28
São Paulo 28
Romola 24
Houston 23
Buffalo 22
Council Bluffs 22
San Francisco 21
Woodbridge 21
Chicago 20
Redondo Beach 19
Olomouc 17
Orem 16
Shanghai 16
Turku 16
Brno 15
Denver 15
Mumbai 14
Rio de Janeiro 14
Seattle 14
Tokyo 14
London 13
Manchester 13
Vienna 13
Frankfurt am Main 12
Montreal 12
Stockholm 12
Milan 11
Warsaw 11
Boston 10
Jacksonville 10
Wilmington 10
Atlanta 9
Brooklyn 9
Curitiba 9
Belo Horizonte 8
Cambridge 8
Charlotte 8
Phoenix 8
Poplar 8
Ribeirão Preto 8
Toronto 8
Amsterdam 7
Chandler 7
Düsseldorf 7
Helsinki 7
Porto Alegre 7
Chennai 6
Hải Dương 6
Mexico City 6
Nairobi 6
Tashkent 6
Amman 5
Brussels 5
Buenos Aires 5
Cape Town 5
Dearborn 5
Goiânia 5
Guayaquil 5
Jinan 5
Johannesburg 5
New Delhi 5
Ottawa 5
Padova 5
Quito 5
São José dos Campos 5
Biên Hòa 4
Brasília 4
Cotia 4
Da Nang 4
Dhaka 4
Imperatriz 4
Ipatinga 4
Kunming 4
Nanjing 4
Nova Iguaçu 4
Petrolina 4
Princeton 4
Riyadh 4
Rome 4
Santiago 4
Santo André 4
Totale 2.226
Salva come PNG Salva come JPEG
Nome #
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 216
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 199
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study 92
Comparison of visual criteria for amyloid-pet reading: Could criteria merging reduce inter-rater variability? 89
Applying the ATN scheme in a memory clinic population: The ABIDE project 89
Clinical utility of FDG-PET for the clinical diagnosis in MCI 88
Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise? 87
AMYPAD Diagnostic and Patient Management Study: Rationale and design 86
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe 85
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia 85
Brain atrophy in Alzheimer's Disease and aging 84
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus 84
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 84
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 82
Medial temporal lobe atrophy and posterior atrophy scales normative values 81
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders 81
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 79
Dementia prevention in memory clinics: recommendations from the European task force for brain health services 79
Plasma biomarkers for Alzheimer's disease: A field-test in a memory clinic 78
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial 78
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults with Subjective Cognitive Decline 76
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia 76
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 74
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised 74
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 74
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease 73
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer’s disease 71
Dementia risk communication. A user manual for Brain Health Services—part 3 of 6 71
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease 70
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia 70
Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design 68
Comment: Is a Large-Scale Screening for Alzheimer's Disease Possible? Yes, in a Few Years 67
Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6 65
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison 63
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact 63
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET 63
Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset 63
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study 62
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies 61
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design 61
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 61
Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration 61
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives 54
Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6 53
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 53
Multitracer model for staging cortical amyloid deposition using PET imaging 47
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study 45
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project 44
Feasibility of a standard cognitive assessment in European academic memory clinics 40
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey 36
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology 29
The detection of GRN mutation carriers by progranulin blood protein levels from finger-stick collection 13
Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial 13
Totale 3.840
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.429
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 3 4 1
2021/202222 1 0 1 2 0 0 1 2 5 2 2 6
2022/202316 3 1 0 3 1 5 0 0 3 0 0 0
2023/2024214 3 2 7 0 0 11 2 1 5 55 16 112
2024/20251.152 31 1 57 148 76 79 137 17 189 84 195 138
2025/20262.230 221 367 201 362 234 149 326 68 147 155 0 0
Totale 3.840